Exabis Library
Welcome to the e-CCO Library!
DOP66: The effect of exclusive enteral nutrition on circulating inflammatory protein levels in paediatric patients with Crohn’s Disease
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
DOP67 CKD-506, a selective histone deacetylase (HDAC) 6 inhibitor, ameliorates colitis through regulation of NF-kB and AP-1 signalling pathway
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
DOP67: A transcriptional module associated with neutrophil degranulation is highly conserved across species and is a core molecular pathway of treatment resistance in ulcerative colitis
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 2:22 PM
DOP67: A transcriptional module associated with neutrophil degranulation is highly conserved across species and is a core molecular pathway of treatment resistance in ulcerative colitis
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 10:43 AM
DOP67: CKD-506, a selective histone deacetylase (HDAC) 6 inhibitor, ameliorates colitis through regulation of NF-kB and AP-1 signaling pathway
2020
ECCO'20 Vienna
Tuesday, 23 June 2020, 5:40 PM
DOP67: CKD-506, a selective histone deacetylase (HDAC) 6 inhibitor, ameliorates colitis through regulation of NF-kB and AP-1 signaling pathway
2020
ECCO'20 Vienna
Tuesday, 23 June 2020, 4:58 PM
1
DOP67: Comparison of the pharmacokinetics of CT-P13 between Crohn’s Disease and Ulcerative Colitis in biologic-naïve patients; a prospective multi-center observational study of the KASID
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
DOP67: First-line infliximab is cost-effective compared to conventional treatment in paediatric Crohn’s Disease – Results from the TISKids study
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
DOP67: Magnification endoscopy with optical chromoendoscopy for in vivo assessment of histological inflammation in patients with inflammatory bowel disease
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
DOP67: Magnification endoscopy with optical chromoendoscopy for in vivo assessment of histologic inflammation in patients with inflammatory bowel disease
2019
ECCO'19 Copenhagen
Tuesday, 28 May 2019, 3:32 PM
1
DOP67: MB310: From Clinical FMT to a Phase 1 Study with a Defined, Orally Administered Live Bacterial Therapeutic for Mild Moderate Ulcerative Colitis
2024
ECCO'24 Stockholm
Tuesday, 30 April 2024, 5:03 PM
DOP68 Thiomyristoyl ameliorates colitis by blocking the differentiation of Th17 cells via STAT3/IL-6 signal pathway
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
DOP68: Assessment of patients' understanding of Inflammatory Bowel Diseases (IBD): Development and validation of a questionnaire (U-IBDQ)
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
DOP68: Autophagy induction in the intestinal epithelium protects against inflammation-induced barrier loss in vivo.
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 2:22 PM
DOP68: Autophagy induction in the intestinal epithelium protects against inflammation-induced barrier loss in vivo.
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 10:43 AM
DOP68: CD-TREAT diet induces remission and improves quality of life in an open label trial in children and adults with active Crohn’s Disease
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
DOP68: Histological remission (NANCY index) is superior to endoscopic mucosal healing in predicting relapse-free survival in patients with ulcerative colitis in clinical and endoscopic remission
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
DOP68: Natural history of isolated Crohn's Disease perianal fistula
2024
ECCO'24 Stockholm
Tuesday, 30 April 2024, 5:03 PM
DOP69 Tofacitinib in ulcerative colitis: Early ‘real-world’ experience from four UK tertiary centres
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
DOP69: Glycans as an actor in the microbiome-immune response crosstalk.
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 2:22 PM